Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
If pantoprazole is not controlling your acid reflux, alternatives include switching to a different proton pump inhibitor such as omeprazole, esomeprazole, lansoprazole, or rabeprazole, adding or switching to an H2 blocker like famotidine, using antacids or alginates such as Gaviscon for fast relief, or asking about newer options like vonoprazan, plus prokinetics, baclofen, or surgical and endoscopic procedures for persistent cases. Timing, dosing, diet and weight changes, and whether your symptoms are actually caused by reflux all affect which option will work, and some "treatment-resistant" reflux turns out to be a different condition entirely, such as functional heartburn, eosinophilic esophagitis, gastroparesis, or an H. pylori infection. There are several important factors to consider, including warning signs like trouble swallowing, weight loss, vomiting, or chest pain that need prompt evaluation, so review the complete answer below before changing your medication. Because the right next step depends on your specific pattern of symptoms, a free, instant, online symptom check can help you clarify what may be driving your reflux and what to raise with your doctor. It takes only a few minutes, costs nothing, and gives you a clearer starting point than guessing at your next medication.
Last reviewed for medical accuracy: 09/14/2026
If pantoprazole isn’t easing your acid reflux, you’re not alone. Up to 30% of people don’t respond fully to one proton-pump inhibitor (PPI) and need other options. Below is a straightforward look at what you can try—both medicines and lifestyle changes—based on clinical guidelines and expert opinion. Always speak with a doctor about anything that could be life-threatening or serious.
Not all PPIs work exactly the same for every person. If pantoprazole fails, your doctor may switch you to:
Each PPI has a slightly different metabolism and strength. Sometimes, a once-daily dose shifted to twice daily (before breakfast and before dinner) can make a difference. Never increase your dose without a doctor’s approval.
Histamine-2 receptor antagonists reduce stomach acid differently from PPIs. They can be used alone or alongside a PPI for “breakthrough” symptoms in the evening:
These are often available over the counter. They tend to work faster than PPIs, though their effect is shorter lived.
Antacids neutralize existing stomach acid and act within minutes. They’re best for occasional flare-ups:
Keep in mind antacids don’t prevent future reflux; they only ease current discomfort.
Alginates form a foam barrier that floats on top of stomach contents, physically blocking reflux:
People who don’t fully respond to PPIs sometimes find alginates very helpful, especially at bedtime.
If slow stomach emptying or a weak lower esophageal sphincter (LES) is part of your reflux, prokinetics can help move food through more quickly:
These medicines must be prescribed and monitored closely.
Even the best medication can fall short if lifestyle and diet factors aren’t addressed. Simple changes can make a big difference:
Persistent reflux despite optimal medicines could be due to:
Your doctor may recommend an upper endoscopy, esophageal pH monitoring or motility studies to look for these conditions.
When lifestyle tweaks, PPIs and other meds fail, procedural treatments may be appropriate:
These are typically reserved for people with documented reflux who don’t respond to maximal medical therapy.
Acid reflux is common, but certain symptoms warrant urgent evaluation:
If you notice any of these, speak to a doctor immediately or visit your nearest emergency department.
When changing or adding treatments, track your reflux frequency and severity:
If you’re unsure what’s causing your symptoms, consider doing a free, online symptom check using the doctor-approved Ubie Symptom Checker. It can help you organize your concerns before your visit.
Refractory reflux can be frustrating, but most people find relief by combining the right medication, diet and lifestyle changes. Always keep your healthcare provider in the loop about new or worsening symptoms. And remember, nothing in this guide replaces personalized medical advice—speak to a doctor about anything that could be life-threatening or serious.
(References)
* Miner P Jr, Katz PO, Chen Y, Sostek M. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x. PMID: 14687806.
* Murtaza G, Khalid MF, Mungo NA. Recurrent Pantoprazole-Associated Pancreatitis. Am J Ther. 2018 Jul/Aug;25(4):e492-e493. doi: 10.1097/MJT.0000000000000567. PMID: 28282309.
* Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018 Jan;154(2):302-318. doi: 10.1053/j.gastro.2017.07.049. Epub 2017 Aug 5. PMID: 28827081.
* Kellerman R, Kintanar T. Gastroesophageal Reflux Disease. Prim Care. 2017 Dec;44(4):561-573. doi: 10.1016/j.pop.2017.07.001. Epub 2017 Oct 5. PMID: 29132520.
* Delshad SD, Almario CV, Chey WD, Spiegel BMR. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms. Gastroenterology. 2020 Apr;158(5):1250-1261.e2. doi: 10.1053/j.gastro.2019.12.014. Epub 2019 Dec 19. PMID: 31866243; PMCID: PMC7103516.
* Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Ann N Y Acad Sci. 2021 Feb;1486(1):3-14. doi: 10.1111/nyas.14501. Epub 2020 Oct 4. PMID: 33015827; PMCID: PMC9792178.
* Zerbib F, Bredenoord AJ, Fass R, Kahrilas PJ, Roman S, Savarino E, Sifrim D, Vaezi M, Yadlapati R, Gyawali CP. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease. Neurogastroenterol Motil. 2021 Apr;33(4):e14075. doi: 10.1111/nmo.14075. Epub 2020 Dec 28. PMID: 33368919.
* Tighe MP, Andrews E, Liddicoat I, Afzal NA, Hayen A, Beattie RM. Pharmacological treatment of gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD008550. doi: 10.1002/14651858.CD008550.pub3. Epub 2023 Aug 22. PMID: 37635269; PMCID: PMC10443045.
* Ortiz-Olvera N, Ochoa-Maya JP, González-Martínez MA. Gastroesophageal reflux disease and pregnancy: recommendations for safe treatment. Gac Med Mex. 2025;161(2):119-126. doi: 10.24875/GMM.M25000986. PMID: 40743550.
* Nalesso G, Ferranti G, Marinescu DC, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Kolb M, Ryerson CJ, CARE-PF Investigators, Other CARE-PF investigators, Cox G, Fell CD, Gershon AS, Goobie G, Grant-Orser A, Khalil N, Lok SD, Minuk L, Morisset J, Sadatsafavi M, Shapera S, To T, Wong AW. Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease. Respir Med. 2026 May;256:108808. doi: 10.1016/j.rmed.2026.108808. Epub 2026 Apr 6. PMID: 41951189.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.